FDA_Decentralized Clinical Trials
FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance On May 2, 2023, the U.S. Food and Drug Administration (FDA) has issued a novel Draft Guidance to further support the use of decentralized clinical trials (DCTs) for drugs, biological products, and devices. This guidance has recommendations for sponsors, investigators and other industry stakeholders regarding the implementation of DCTs to advance medical product development and research. DCTs
Head of Operations, Turkey
Cromos Pharma Appoints Elçin Gulistanoglu as New Head of Operations in Türkiye Elçin is an experienced clinical research professional with a career spanning over 20 years. Her extensive knowledge in multiple therapeutic areas, including oncology, adult and pediatric endocrinology, vaccinology and rheumatology makes her a welcome addition to Cromos Pharma’s highly professional team. Elçin has held a variety of senior clinical development positions in the leading international
World Hemophilia Day 2023
World Hemophilia Day 2023 Every year April 17 is observed as World Hemophilia Day. It brings attention to a rare bleeding illness that impairs the blood’s ability to clot and offers an opportunity to spread awareness of the illness, its signs and symptoms, available treatments, and the difficulties that people with Hemophilia and other bleeding disorders encounter every day.
Happy Easter, Easter holidays, Easter
Happy Easter!

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us